cis-Bac430

1 1

Selleck Chemicals

E4958-5MG

€390,00 EUR
€390,00 EUR
Sold out
Shipping calculated at checkout.
Supplier
Size
View full details

cis-Bac430 is an inhibitor of Immune Checkpoints used in studies of Immune Signaling. It is especially relevant in cancer, immunology, and inflammation models, where defined compound exposure can be linked to cytokine-mediated signaling and inflammatory effector responses.

By inhibiting Immune Checkpoints, cis-Bac430 can be used to examine cytokine-mediated signaling and inflammatory effector responses. The immunomodulator annotation adds relevance to immune-cell activation, cytokine, and mediator assays, together with downstream-response mapping in the same experimental setting. In cancer, immunology, and inflammation models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

  • Target-focused assays involving Immune Checkpoints
  • Pathway perturbation studies connected to Immune Signaling
  • Concentration-response inhibition and target-dependence studies
  • Immune-cell activation, cytokine, and mediator assays

Overall, cis-Bac430 is appropriate when a defined chemical perturbant is needed to connect Immune Checkpoints with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cancer, immunology, and inflammation models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.

Targets:
Immune Checkpoints
Target Class:
Immunomodulator
Pathways:
Immune Signaling
Research Area:
Cancer • Immunology • Inflammation
CAS No.:
2227449-70-7
Molecular Weight:
429.64
Formula:
C₂₇H₄₃NO₃
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.